213 related articles for article (PubMed ID: 32311408)
1. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
Mukherjee S; Patra R; Behzadi P; Masotti A; Paolini A; Sarshar M
Front Immunol; 2023; 14():1244345. PubMed ID: 37822929
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
Hanke ML; Kielian T
Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications.
Chen YH; Wu KH; Wu HP
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732254
[TBL] [Abstract][Full Text] [Related]
5. Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
Agarwal M; Kumar M; Pathak R; Bala K; Kumar A
Int Rev Cell Mol Biol; 2024; 385():227-261. PubMed ID: 38663961
[TBL] [Abstract][Full Text] [Related]
6. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy.
Chakraborty S; Ye J; Wang H; Sun M; Zhang Y; Sang X; Zhuang Z
Front Immunol; 2023; 14():1227833. PubMed ID: 37936697
[TBL] [Abstract][Full Text] [Related]
7. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
Qi SY; Yang MM; Li CY; Yu K; Deng SL
Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: new regulators of Toll-like receptor signalling pathways.
He X; Jing Z; Cheng G
Biomed Res Int; 2014; 2014():945169. PubMed ID: 24772440
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review on the dynamic role of toll-like receptors (TLRs) in frontier aquaculture research and as a promising avenue for fish disease management.
Mahapatra S; Ganguly B; Pani S; Saha A; Samanta M
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126541. PubMed ID: 37648127
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer and Toll-like receptors.
Pinto A; Morello S; Sorrentino R
Cancer Immunol Immunother; 2011 Sep; 60(9):1211-20. PubMed ID: 21789594
[TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor-Based Strategies for Cancer Immunotherapy.
Pahlavanneshan S; Sayadmanesh A; Ebrahimiyan H; Basiri M
J Immunol Res; 2021; 2021():9912188. PubMed ID: 34124272
[TBL] [Abstract][Full Text] [Related]
12. Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Jin M; Fang J; Wang JJ; Shao X; Xu SW; Liu PQ; Ye WC; Liu ZP
Acta Pharmacol Sin; 2023 Dec; 44(12):2358-2375. PubMed ID: 37550526
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors in health and disease.
Wang K; Huang H; Zhan Q; Ding H; Li Y
MedComm (2020); 2024 May; 5(5):e549. PubMed ID: 38685971
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges.
Yang Y; Li H; Fotopoulou C; Cunnea P; Zhao X
Front Immunol; 2022; 13():1049340. PubMed ID: 36479129
[TBL] [Abstract][Full Text] [Related]
15. Modulation of adaptive immunity with Toll-like receptors.
Manicassamy S; Pulendran B
Semin Immunol; 2009 Aug; 21(4):185-93. PubMed ID: 19502082
[TBL] [Abstract][Full Text] [Related]
16. Phosphatases in toll-like receptors signaling: the unfairly-forgotten.
Lannoy V; Côté-Biron A; Asselin C; Rivard N
Cell Commun Signal; 2021 Jan; 19(1):10. PubMed ID: 33494775
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.
Mokhtari Y; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
J Cell Mol Med; 2021 Jan; 25(2):639-651. PubMed ID: 33336901
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?
Killeen SD; Wang JH; Andrews EJ; Redmond HP
Br J Cancer; 2006 Aug; 95(3):247-52. PubMed ID: 16892041
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors expressed in tumor cells: targets for therapy.
Yu L; Chen S
Cancer Immunol Immunother; 2008 Sep; 57(9):1271-8. PubMed ID: 18256828
[TBL] [Abstract][Full Text] [Related]
20. TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer.
Cui L; Wang X; Zhang D
Front Cell Dev Biol; 2020; 8():611444. PubMed ID: 33469538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
